RPRX Royalty Pharma plc Stock Quote

RPRX [NASD]

Index	-	P/E	40.06	EPS (ttm)	1.00	Insider Own	0.20%	Shs Outstand	433.96M	Perf Week	0.55%
Market Cap	23.65B	Forward P/E	11.81	EPS next Y	3.38	Insider Trans	-41.65%	Shs Float	195.99M	Perf Month	-5.89%
Income	602.40M	PEG	3.58	EPS next Q	0.80	Inst Own	63.20%	Short Float	3.76%	Perf Quarter	0.20%
Sales	2.28B	P/S	10.38	EPS this Y	13.30%	Inst Trans	0.41%	Short Ratio	3.57	Perf Half Y	-0.62%
Book/sh	13.31	P/B	3.00	EPS next Y	12.81%	ROA	3.50%	Target Price	52.00	Perf Year	-1.94%
Cash/sh	4.92	P/C	8.12	EPS next 5Y	11.20%	ROE	10.40%	52W Range	34.86 - 47.10	Perf YTD	0.23%
Dividend	0.76	P/FCF	-	EPS past 5Y	-	ROI	11.10%	52W High	-15.35%	Beta	-
Dividend %	1.90%	Quick Ratio	22.00	Sales past 5Y	-	Gross Margin	-	52W Low	14.37%	ATR	1.32
Employees	66	Current Ratio	22.00	Sales Q/Q	-1.90%	Oper. Margin	62.40%	RSI (14)	45.60	Volatility	3.78% 2.96%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-25.10%	Profit Margin	26.40%	Rel Volume	0.52	Prev Close	39.94
Shortable	Yes	LT Debt/Eq	1.23	Earnings	May 05 BMO	Payout	48.20%	Avg Volume	2.07M	Price	39.87
Recom	2.10	SMA20	-4.30%	SMA50	-1.12%	SMA200	1.74%	Volume	315,234	Change	-0.18%

May-13-22

Initiated

Scotiabank

Sector Outperform

$53

Apr-27-22

Initiated

Goldman

Buy

$56

Apr-14-22

Upgrade

JP Morgan

Neutral → Overweight

$50

Apr-06-22

Resumed

Morgan Stanley

Overweight

$48

Oct-29-21

Upgrade

Citigroup

Neutral → Buy

$50

Jul-30-21

Initiated

Tigress Financial

Buy

$50

Nov-09-20

Upgrade

UBS

Neutral → Buy

$52 → $51

Jul-14-20

Initiated

Evercore ISI

In-line

Jul-13-20

Initiated

UBS

Neutral

$52

Jul-13-20

Initiated

SunTrust

Buy

$56

Jul-13-20

Initiated

Morgan Stanley

Equal-Weight

$51

Jul-13-20

Initiated

JP Morgan

Neutral

$50

Jul-13-20

Initiated

Goldman

Neutral

$47

Jul-13-20

Initiated

Cowen

Outperform

$55

Jul-13-20

Initiated

Citigroup

Neutral

$50

Jul-13-20

Initiated

BofA Securities

Buy

$55

May-05-22 07:00AM	Royalty Pharma Reports First Quarter 2022 Results GlobeNewswire -5.63%
May-04-22 03:32PM	With Royalty Pharma plc (NASDAQ:RPRX) It Looks Like You'll Get What You Pay For Simply Wall St.
Apr-18-22 08:00AM	Royalty Pharma Declares Second Quarter 2022 Dividend GlobeNewswire
Apr-13-22 08:00AM	Royalty Pharma to Announce First Quarter 2022 Financial Results on May 5, 2022 GlobeNewswire
Mar-29-22 08:00AM	Royalty Pharma Announces Charitable Alliance with The Leukemia & Lymphoma Society (LLS) To Advance Initiatives that Address Healthcare Disparities in Blood Cancer Care and Treatment PR Newswire
Mar-15-22 09:48AM	Investors in Royalty Pharma (NASDAQ:RPRX) have unfortunately lost 18% over the last year Simply Wall St.
Mar-03-22 08:30AM	Royalty Pharma to Present at Cowen's 42nd Annual Health Care Conference GlobeNewswire
Mar-01-22 03:34AM	Top Growth Stocks for March 2022 Investopedia
Feb-25-22 09:01PM	Top Healthcare Stocks for March 2022 Investopedia
Feb-16-22 08:15AM	Royalty Pharma Announces Inaugural Investor Day GlobeNewswire
Feb-15-22 07:00AM	Royalty Pharma Reports Q4 and Full Year 2021 Results GlobeNewswire
Feb-08-22 01:38PM	S&co Inc Buys Royalty Pharma PLC, Edwards Lifesciences Corp, Procter & Gamble Co, Sells ... GuruFocus.com
Feb-07-22 01:38PM	Financial Consulate, Inc Buys iShares J.P. ... GuruFocus.com
12:03PM	Rivian, Robinhood, Bumble: Many top IPOs of 2021 are struggling Yahoo Finance Video
Feb-04-22 05:38PM	Torray LLC Buys General Motors Co, T. Rowe Price Group Inc, Applied Materials Inc, Sells Intel ... GuruFocus.com
03:11PM	Largest IPOs of 2021 struggling as public companies Yahoo Finance Video
Jan-31-22 01:38PM	State of New Jersey Common Pension Fund D Buys Canadian Pacific Railway, Airbnb Inc, Lucid ... GuruFocus.com
Jan-27-22 01:38PM	Oxler Private Wealth LLC Buys Ford Motor Co, Verizon Communications Inc, Zoom Video ... GuruFocus.com
Jan-20-22 07:45AM	Royalty Pharma to Announce Fourth-Quarter and Full-Year 2021 Financial Results on February 15, 2022 GlobeNewswire
Jan-18-22 02:57PM	Top Biotech Stocks for Q1 2022 Investopedia
Jan-14-22 07:05AM	Royalty Pharma (NASDAQ:RPRX) Has Announced That It Will Be Increasing Its Dividend To US$0.19 Simply Wall St.
Jan-10-22 07:00AM	Royalty Pharma Highlights Accomplishments and Provides Business Update at 40th Annual J.P. Morgan Healthcare Conference GlobeNewswire +5.41%
Jan-07-22 08:07AM	Royalty Pharma and Cytokinetics Announce Funding Agreements Totaling up to $450 Million GlobeNewswire
07:30AM	Cytokinetics and Royalty Pharma Announce Funding Agreements Totaling up to $450 Million GlobeNewswire
Jan-06-22 08:30AM	Royalty Pharma Announces 12% Dividend Increase GlobeNewswire
Jan-05-22 04:15PM	Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 10 GlobeNewswire
Dec-27-21 02:54PM	Gilead Sciences sued over royalty payments on key HIV drug American City Business Journals
Dec-16-21 09:38AM	VIP Health Care Portfolio Buys Thermo Fisher Scientific Inc, Royalty Pharma PLC, Charles River ... GuruFocus.com
Dec-06-21 11:00AM	Royalty Pharma plc (NASDAQ:RPRX) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? Simply Wall St.
Nov-29-21 04:15PM	Royalty Pharma to Present at Evercore ISI 4th Annual HealthCONx Virtual Conference GlobeNewswire
Nov-23-21 07:21AM	Durham drugmaker scores another cash infusion. This time it's $350 million. American City Business Journals
Nov-22-21 07:10AM	Royalty Pharma Acquires Additional Royalty Interests in BCX9930 and ORLADEYO from BioCryst Pharmaceuticals GlobeNewswire
Nov-19-21 06:46PM	Warren Buffett keeps selling billions worth of stock in this frothy market here are 3 new places where he's finding value MoneyWise
Nov-10-21 07:00AM	Royalty Pharma Reports Third Quarter 2021 Results GlobeNewswire +5.00%
Nov-09-21 11:16PM	Were Hedge Funds Right About Royalty Pharma Plc (RPRX)? Insider Monkey
Oct-18-21 09:00AM	Royalty Pharma to Announce Third-Quarter 2021 Financial Results on November 10, 2021 GlobeNewswire
Oct-15-21 09:00AM	Royalty Pharma Declares Fourth-Quarter 2021 Dividend GlobeNewswire
Oct-11-21 09:18AM	Harvard University Stock Portfolio: Top 10 Picks Insider Monkey
Sep-29-21 11:48AM	Shareholders in Royalty Pharma (NASDAQ:RPRX) are in the red if they invested a year ago Simply Wall St.
Sep-03-21 09:00AM	Royalty Pharma to Present at Upcoming Investor Conferences GlobeNewswire
Aug-11-21 07:00AM	Royalty Pharma Reports Second Quarter 2021 Results GlobeNewswire
Jul-29-21 07:02AM	What Type Of Shareholders Own The Most Number of Royalty Pharma plc (NASDAQ:RPRX) Shares? Simply Wall St.
Jul-19-21 09:00AM	Royalty Pharma to Announce Second-Quarter 2021 Financial Results on August 11, 2021 GlobeNewswire
Jul-16-21 09:00AM	Royalty Pharma Declares Third-Quarter 2021 Dividend GlobeNewswire
Jul-15-21 04:54PM	Royalty Pharma Announces Pricing of $1.3 Billion of Senior Unsecured Notes, Including $600 Million Social Bond GlobeNewswire
Jul-13-21 10:41AM	Hedge Funds Are Crazy About Royalty Pharma Plc (RPRX) Insider Monkey
Jul-05-21 05:30AM	Midsize Pharmaceutical Firms Are the Industrys Big Deal Makers This Year The Wall Street Journal
Jun-07-21 09:00AM	Royalty Pharma to Present at Upcoming Investor Conferences GlobeNewswire
Jun-02-21 07:40AM	Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership With MorphoSys GlobeNewswire +6.68%
May-18-21 08:49AM	Declining Stock and Decent Financials: Is The Market Wrong About Royalty Pharma plc (NASDAQ:RPRX)? Simply Wall St.
May-11-21 08:00PM	Repros Therapeutics (RPRX) Q1 2021 Earnings Call Transcript Motley Fool
07:00AM	Royalty Pharma Reports First Quarter 2021 Results GlobeNewswire
05:45AM	Royalty Pharma plc - Ordinary Shares - Class A to Host Earnings Call ACCESSWIRE
May-07-21 09:00AM	Royalty Pharma to Present at Upcoming Investor Conferences GlobeNewswire
Apr-21-21 04:15PM	Royalty Pharma to Announce First-Quarter 2021 Financial Results on May 11, 2021 GlobeNewswire
08:10AM	Royalty Pharma Announces Strategic Alliance With MSCI to Launch Life Sciences Indexes GlobeNewswire
Apr-15-21 09:00AM	Royalty Pharma Declares Second-Quarter 2021 Dividend GlobeNewswire
Apr-08-21 07:40AM	Royalty Pharma Acquires OXLUMO Royalty Interest From Dicerna for up to $240 Million GlobeNewswire
07:30AM	Dicerna Sells OXLUMO (lumasiran) Royalty Interest to Royalty Pharma for Up to $240 Million Business Wire
Apr-01-21 07:30AM	Royalty Pharma Acquires Royalty Interest in Cabozantinib From GSK GlobeNewswire
Mar-30-21 08:00AM	Royalty Pharma Appoints Henry A. Fernandez as Lead Independent Director GlobeNewswire
Mar-11-21 02:37PM	Spot Emerging Growth Stocks Like Upstart, Fiserv By Following The Smart Money Investor's Business Daily
Feb-17-21 12:30PM	Repros Therapeutics (RPRX) Q4 2020 Earnings Call Transcript Motley Fool
07:00AM	Royalty Pharma Reports Q4 2020 and Full-Year Results GlobeNewswire
05:45AM	Royalty Pharma plc - Ordinary Shares - Class A to Host Earnings Call ACCESSWIRE
Feb-15-21 05:30AM	Is Royalty Pharma plc's (NASDAQ:RPRX) Shareholder Ownership Skewed Towards Insiders? Simply Wall St.
Jan-29-21 11:35PM	15 Biggest IPOs of 2020 Insider Monkey
Jan-22-21 08:00AM	Royalty Pharma to Announce Fourth-Quarter 2020 Financial Results on February 17, 2021 GlobeNewswire
Jan-19-21 08:30AM	Royalty Pharma Acquires Royalty Interest in Seltorexant From Minerva Neurosciences GlobeNewswire
08:00AM	Minerva Neurosciences and Royalty Pharma Announce Sale of Seltorexant Royalty for up to $155 Million GlobeNewswire
Jan-08-21 08:05AM	Royalty Pharma increases quarterly dividend by 13% to 17 cents a share MarketWatch
08:00AM	Royalty Pharma Announces 13% Dividend Increase GlobeNewswire
Jan-07-21 04:15PM	Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 12 GlobeNewswire
Dec-23-20 03:16PM	IPOs to watch in 2021: The 5 most anticipated debuts Yahoo Finance
Dec-22-20 08:30AM	Royalty Pharma Announces Charitable Gifts to Support COVID-19 Research at Leading Hospitals and Universities GlobeNewswire +5.07%
Dec-21-20 08:12AM	Royalty Pharma Announces Expansion of Leadership Team GlobeNewswire
Dec-17-20 04:29PM	Is RPRX A Good Stock To Buy Now? Insider Monkey
Dec-07-20 08:45AM	Royalty Pharma Acquires Royalty Interest in ORLADEYO and BCX9930 From BioCryst Pharmaceuticals GlobeNewswire
08:40AM	BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management GlobeNewswire
Dec-04-20 04:31PM	Biotech, Life Sciences IPOs Score Double-Digit Gains Barrons.com
Nov-16-20 03:39AM	Can Royalty Pharma plc's (NASDAQ:RPRX) ROE Continue To Surpass The Industry Average? Simply Wall St.
Nov-10-20 05:40PM	Royalty Pharma Reports Third Quarter 2020 Results GlobeNewswire
Nov-02-20 07:30AM	Royalty Pharma Acquires Additional Royalty Interest From the Cystic Fibrosis Foundation GlobeNewswire
Oct-20-20 04:32PM	Royalty Pharma Announces Closing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders GlobeNewswire
Oct-19-20 09:00AM	Royalty Pharma to Announce Third-Quarter 2020 Financial Results on November 11, 2020 GlobeNewswire
Oct-15-20 11:45PM	Royalty Pharma Announces Pricing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders GlobeNewswire
09:15AM	Royalty Pharma Declares Fourth-Quarter 2020 Dividend GlobeNewswire
Oct-13-20 04:10PM	Royalty Pharma Announces Secondary Offering of Class A Ordinary Shares by Selling Shareholders GlobeNewswire
Oct-02-20 07:00AM	New Ventures Funds Rebrands as Scientia Ventures PR Newswire
Sep-16-20 11:42AM	Royalty Pharma plc (NASDAQ:RPRX) Shares Could Be 41% Below Their Intrinsic Value Estimate Simply Wall St.
Sep-02-20 04:25PM	Royalty Pharma Announces Closing of $6.0 Billion Senior Unsecured Notes GlobeNewswire
08:00AM	Royalty Pharma Declares Third-Quarter 2020 Dividend GlobeNewswire
Aug-25-20 08:14AM	Royalty Pharma prices $6 billion bond deal that is its first as a public company MarketWatch
08:00AM	Royalty Pharma Announces Pricing of $6.0 Billion Senior Unsecured Notes GlobeNewswire
Aug-19-20 09:00AM	Royalty Pharma Announces Launch of Senior Notes Offering GlobeNewswire
Aug-12-20 07:00AM	Royalty Pharma Reports Second Quarter 2020 Results GlobeNewswire
Aug-07-20 09:40AM	Biohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 Million GlobeNewswire
Aug-03-20 04:15PM	Royalty Pharma Appoints Henry A. Fernandez and Ted W. Love, M.D. to the Companys Board of Directors GlobeNewswire
Jul-20-20 04:15PM	Royalty Pharma to Announce Second-Quarter 2020 Financial Results on August 12 GlobeNewswire
07:45AM	Royalty Pharma Acquires Royalty Interest in Risdiplam From PTC Therapeutics GlobeNewswire

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 45 marketed therapies and 9 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RIGGS RORY B	Director	Mar 29	Sale	38.59	60,000	2,315,322	601,712	Mar 30 06:46 PM
RIGGS RORY B	Director	Mar 21	Sale	39.05	39,867	1,556,846	0	Mar 21 06:20 PM
RIGGS RORY B	Director	Mar 18	Sale	39.55	129,222	5,110,675	14,322	Mar 21 06:20 PM
Fernandez Henry A	Director	Feb 24	Buy	37.49	32,500	1,218,373	58,200	Feb 25 07:21 PM
RIGGS RORY B	Director	Dec 29	Sale	40.00	75,000	3,000,352	592,748	Dec 30 06:07 PM
RIGGS RORY B	Director	Dec 28	Sale	40.21	109,448	4,400,415	301,974	Dec 30 06:07 PM
RIGGS RORY B	Director	Nov 17	Sale	42.34	139,389	5,902,285	500,549	Nov 18 07:15 PM
RIGGS RORY B	Director	Nov 17	Sale	42.39	62,435	2,646,401	622,398	Nov 18 07:15 PM
Lloyd George W.	EVP, Investments & GC	Nov 17	Sale	42.39	84,148	3,566,832	630,000	Nov 18 07:18 PM
Lloyd George W.	EVP, Investments & GC	Nov 16	Sale	42.39	165,852	7,029,862	495,860	Nov 18 07:18 PM
RIGGS RORY B	Director	Nov 16	Sale	42.01	12,565	527,805	684,833	Nov 18 07:15 PM
RIGGS RORY B	Director	Sep 29	Sale	36.35	63,777	2,318,494	899,306	Sep 30 03:56 PM
RIGGS RORY B	Director	Sep 29	Sale	36.50	24,648	899,706	615,112	Sep 30 03:56 PM
RIGGS RORY B	Director	Sep 28	Sale	36.75	40,000	1,470,088	639,760	Sep 30 03:56 PM
Lloyd George W.	EVP, Investments & GC	Jul 26	Sale	39.78	13,362	531,532	595,860	Jul 27 05:29 PM
Reddoch James F.	EVP, Research & Investments	Jul 26	Sale	39.78	8,949	355,977	1,170,800	Jul 27 05:25 PM
Reddoch James F.	EVP, Research & Investments	Jul 26	Sale	39.78	8,949	355,977	1,170,800	Jul 27 05:23 PM
Reddoch James F.	EVP, Research & Investments	Jul 14	Sale	42.00	2	84	1,179,749	Jul 14 05:17 PM
Reddoch James F.	EVP, Research & Investments	Jul 13	Sale	42.01	17,832	749,081	1,179,751	Jul 14 05:17 PM
Lloyd George W.	EVP, Investments & GC	Jul 13	Sale	42.01	23,049	968,252	600,773	Jul 14 05:18 PM
Lloyd George W.	EVP, Investments & GC	Jul 12	Sale	42.04	100	4,204	806,430	Jul 14 05:18 PM
Reddoch James F.	EVP, Research & Investments	Jul 12	Sale	42.04	100	4,204	1,197,583	Jul 14 05:17 PM
Lloyd George W.	EVP, Investments & GC	Jul 08	Sale	42.05	49,059	2,062,789	605,841	Jul 08 07:36 PM
Reddoch James F.	EVP, Research & Investments	Jul 08	Sale	42.05	40,655	1,709,380	1,197,683	Jul 08 07:37 PM
Reddoch James F.	EVP, Research & Investments	Jul 07	Sale	42.01	2,192	92,087	1,238,338	Jul 08 07:37 PM
Lloyd George W.	EVP, Investments & GC	Jul 07	Sale	42.01	2,900	121,828	614,233	Jul 08 07:36 PM
Lloyd George W.	EVP, Investments & GC	Jul 06	Sale	42.41	36,530	1,549,145	614,633	Jul 08 07:36 PM
Reddoch James F.	EVP, Research & Investments	Jul 06	Sale	42.40	30,270	1,283,560	1,240,530	Jul 08 07:37 PM
RIGGS RORY B	Director	Jun 29	Sale	41.26	481,000	19,844,846	3,451,258	Jun 29 08:31 PM
RIGGS RORY B	Director	Jun 28	Sale	42.11	167,448	7,051,269	3,932,258	Jun 29 08:31 PM
RIGGS RORY B	Director	Jun 25	Sale	42.72	666,464	28,474,019	933,910	Jun 29 08:31 PM
Lloyd George W.	EVP, Investments & GC	Jun 10	Sale	46.49	70,000	3,254,369	240,000	Jun 14 06:42 PM
Lloyd George W.	EVP, Investments & GC	Jun 08	Sale	46.48	70,000	3,253,631	250,000	Jun 08 08:12 PM
Reddoch James F.	EVP, Research & Investments	Jun 08	Sale	46.43	50,000	2,321,540	1,270,800	Jun 08 08:12 PM
Reddoch James F.	EVP, Research & Investments	Jun 07	Sale	46.59	50,000	2,329,419	1,320,800	Jun 08 08:12 PM
Lloyd George W.	EVP, Investments & GC	Jun 07	Sale	46.34	122,500	5,676,228	260,000	Jun 08 08:12 PM
Urist Marshall	EVP & Co-Head of R&I	Jun 07	Sale	47.02	16,568	779,059	0	Jun 08 08:15 PM
Urist Marshall	EVP & Co-Head of R&I	Jun 04	Sale	45.13	16,566	747,662	16,568	Jun 08 08:15 PM
Lloyd George W.	EVP, Investments & GC	Jun 04	Sale	44.78	60,000	2,686,938	280,000	Jun 08 08:12 PM
Reddoch James F.	EVP, Research & Investments	Jun 04	Sale	44.60	100,000	4,459,730	1,370,800	Jun 08 08:12 PM
Urist Marshall	EVP & Co-Head Research & Inv.	Jun 02	Sale	41.52	14,566	604,850	33,134	Jun 04 06:52 PM
Reddoch James F.	EVP, Research & Investments	Jun 02	Sale	42.13	50,000	2,106,560	1,470,800	Jun 04 06:50 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience